Domestic Branded Generics

Our Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under our own brand names through online and offline channels. Our branded generic products are generic medicines for which the patents have expired, that are sold directly to our distributors, stockists & retailers.

Fourteen of the top fifteen Indian pharmaceutical companies that CRISIL Research identified as the largest players in the domestic formulation market in Fiscal 2023 have been a part of our customer base.

We sell our domestic branded generic products through our pan-Indian network of distributors, stockists and pharmacies. Our generic drug products are also available online through various e-commerce pharmacy sites. We have developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

Our products cover the following therapeutic areas:

  • Anticholinergic and Heparin
  • Cephalosporins
  • Proton Pump Inhibitor
  • Anticold and Antiallergic
  • Antiemetic
  • NSAIDs, Analgesics and Antipyretic
  • Antidiabetic
  • Antispasmodic
  • Antifibrinolytic
  • Cardiovascular
  • Antioxidant and Vitamins
  • Antihyperuricemia and Antigout
  • Fluoroquinolone and Macrolide
  • Nootropics and Neurotonics / Neurotrophics
  • Antiulcerative
  • Antimalarial
  • Anxiolytic, Anticonvulsant and Antipsychotic
  • Bladder and Prostate Disorder
  • Antifungal, Anthelmintic and Antiviral
  • Anticholinergic, Anti-Asthmatic and Bronchodilator
  • Erectile Dysfunction

We market our domestic branded generics business through a developed network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies across India. We aim to grow our pan-Indian network to include more retailers and expand our geographic reach. To that end, we are employing a sales and marketing field team to expand our distributor, stockist and retailer relationships and support our new generic product launches.